These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7234217)

  • 1. [Cytogenetic studies for detection of tumour strain lines of ovarian cancer cells (author's transl)].
    Kademann R; Marx B; Krafft W; Kademann J; Preibsch W; Behling H; Brückmann D
    Zentralbl Gynakol; 1981; 103(3):176-80. PubMed ID: 7234217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chromosome aberrations in oncobiogram - cytogenetic studies into aberration frequency following trenimon treatment in vitro (author's transl)].
    Weise W; Kosmowski A
    Zentralbl Gynakol; 1979; 101(20):1297-307. PubMed ID: 539207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heterochromatin polymorphism of A1 chromosome in patients with ovarian carcinoma (author's transl)].
    Adomat W; Weise W
    Zentralbl Gynakol; 1981; 103(15):865-73. PubMed ID: 7304018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular cytogenetic characterization of the stable ovarian carcinoma cell line (OvBH-1).
    Schlade-Bartusiak K; Sasiadek MM; Bar JK; Urbschat S; Blin N; Montenarh M; Harłozińska-Szmyrka A
    Cancer Genet Cytogenet; 2006 Jan; 164(1):10-5. PubMed ID: 16364757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic and cell cycle studies in metastatic cells from ovarian carcinomas.
    Augustus M; Brüderlein S; Gebhart E
    Anticancer Res; 1986; 6(2):283-9. PubMed ID: 3707064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer?
    Panani AD
    Cancer Lett; 2007 Dec; 258(2):262-7. PubMed ID: 17945413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
    Evans MF; McDicken IW; Herrington CS
    J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics.
    Engel H; Kleespies C; Friedrich J; Breidenbach M; Kallenborn A; Schöndorf T; Kolhagen H; Mallmann P
    Br J Cancer; 1999 Dec; 81(7):1165-73. PubMed ID: 10584878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent cytogenetic aberrations in human ovarian carcinomas.
    Kiechle-Schwarz M; Bauknecht T; Schmidt J; Walz L; Pfleiderer A
    Cancer Detect Prev; 1995; 19(3):234-43. PubMed ID: 7750111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of highly radiosensitive cell lines from a human ovarian small-cell cancer.
    Hanson JA; Parry EM; Gibbs AR; Court JB; Pour-Faizi MA; Kerby IJ; Bean EA
    Gynecol Oncol; 1997 Nov; 67(2):147-53. PubMed ID: 9367698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells.
    Wasenius VM; Jekunen A; Monni O; Joensuu H; Aebi S; Howell SB; Knuutila S
    Genes Chromosomes Cancer; 1997 Apr; 18(4):286-91. PubMed ID: 9087568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
    Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
    Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyological and isoenzyme characterization of established human sarcoma cell lines.
    Phan Thu A; Zajac V; Kuliffay P; Popović M
    Neoplasma; 1980; 27(5):557-66. PubMed ID: 6262670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
    Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
    Ruan HY; Li DR; Li L; Guan X; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytogenetic findings in ovarian tumors (author's transl)].
    Knörr-Gärtner H; Schuhmann R; Uebele-Kallhardt B
    Verh Dtsch Ges Pathol; 1973; 57():203-7. PubMed ID: 4142176
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity.
    Testa JR; Getts LA; Salazar H; Liu Z; Handel LM; Godwin AK; Hamilton TC
    Cancer Res; 1994 May; 54(10):2778-84. PubMed ID: 8168110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
    Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
    Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.